Gene · 3818
Papers2,245
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,245
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Continuous-Time Markov Population PK/PD Modeling of Longitudinal EASI Categorical Score in Atopic Dermatitis Treated With Rocatinlimab, an Anti-OX40 Monoclonal Antibody. | CPT Pharmacometrics Syst Pharmacol | 2025 | 40660464 | PubTator, text mining | PubMed |
| Structure and interactions of the proteins from the contact system. | Blood | 2025 | 40638675 | PubTator, text mining | PubMed |
| Differential expression of lncRNAs and mRNAs in bone marrow-derived mesenchymal stem cells under continuous and intermittent teriparatide treatment. | Biomed Pharmacother | 2025 | 40609214 | PubTator, text mining | PubMed |
| Long-term performance evaluation of a 1.5T MR-Linac using statistical process control techniques. | Radiat Oncol | 2025 | 40483491 | PubTator, text mining | PubMed |
| Inhibition of Activated Coagulation Factor XII by the Phosphodiesterase-4 Inhibitor Roflumilast: In Vitro and In Silico Studies. | Front Biosci (Landmark Ed) | 2025 | 40464522 | PubTator, text mining | PubMed |
| Potential therapeutic targets for deep vein thrombosis: A proteome-wide Mendelian randomization study. | Phlebology | 2025 | 40462713 | PubTator, text mining | PubMed |
| Genome-wide association study-driven identification of thrombomodulin and factor V as the best biomarker combination for deep vein thrombosis. | Genomics Inform | 2025 | 40375318 | PubTator, text mining | PubMed |
| Acinetobacter Baumannii Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil Activation. | Circ Res | 2025 | 40357548 | PubTator, text mining | PubMed |
| Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects. | Expert Rev Mol Med | 2025 | 40160040 | PubTator, text mining | PubMed |
| An evaluation of sebetralstat as the first oral on-demand therapy for Hereditary Angioedema. | Expert Opin Pharmacother | 2025 | 40110977 | PubTator, text mining | PubMed |
| Enhancement of plasma kallikrein specificity of antitrypsin variants identified by phage display and partial reversion. | BMC Biotechnol | 2025 | 40075385 | PubTator, text mining | PubMed |
| Plasma Proteomic Assessment of Calcific Aortic Valve Disease in Older Adults. | J Am Heart Assoc | 2025 | 40008515 | PubTator, text mining | PubMed |
| Quantitative proteomics identifies plasma protein alterations that associate with metabolic and thrombotic profile changes after bariatric surgery. | Diabetes Obes Metab | 2025 | 40000393 | PubTator, text mining | PubMed |
| Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group. | Mol Ther Nucleic Acids | 2025 | 39991472 | PubTator, text mining | PubMed |
| Bacterially mediated phosphorus cycling favors resource use efficiency of phytoplankton communities in a eutrophic plateau lake. | Water Res | 2025 | 39987581 | PubTator, text mining | PubMed |
| Comparison of real-world healthcare resource utilization and costs among patients with hereditary angioedema on lanadelumab or berotralstat long-term prophylaxis. | J Comp Eff Res | 2025 | 39976166 | PubTator, text mining | PubMed |
| Platform-dependent effects of genetic variants on plasma APOL1. | bioRxiv | 2025 | 39975113 | PubTator, text mining | PubMed |
| Inflammatory Gene Signature Identified by Machine Algorithms Reveals Novel Biomarkers of Coronary Artery Disease. | J Inflamm Res | 2025 | 39959641 | PubTator, text mining | PubMed |
| A model of zymogen factor XII: insights into protease activation. | Blood Adv | 2025 | 39883942 | PubTator, text mining | PubMed |
| Multi-omics reveals mechanism of hydroxylamine-enhanced ultimate nitrogen removal in pilot-scale anaerobic/aerobic/anoxic system. | Water Res | 2025 | 39787834 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3818/papers?page=3